Press Releases
Home › Press Releases
The news index is intended for investors and media professionals who are looking to learn more about Angiotech. We hope you find this information useful and if you can't find what you are looking for, please feel free to contact us.
All press releases and other information listed below were, to the best of Angiotech's knowledge, timely and accurate when issued. However, the passage of time can render information stale, and you should not rely on the continued accuracy of any such material beyond the date of issuance. Angiotech does not assume the obligation to update this information. All viewers should carefully check the dates of issuance of the material contained in the Angiotech site.
2007
- December 20Athersys and Angiotech Announce Authorization of Phase I Intramyocardial Stem Cell U.S. Clinical Trial in Acute Myocardial Infarction
- December 17Angiotech Submits 510(K) to FDA for its Innovative 5-FU CVC
- November 27Angiotech to Participate in Bank of America 2007 Credit Conference
- November 8Angiotech to Participate in the American Academy of Ophthalmology (AAO) 2007 Annual Meeting - Introducing SharpGuard™ Microsurgical Guarded Knives for Use in Ophthalmic Surgery
- November 1Angiotech Reports Third Quarter Results
- October 30Angiotech to Participate in CIBC 18th Annual Healthcare Conference
- October 25Notice of Conference Call and Webcast: Angiotech's Third Quarter 2007 Financial Results
- October 19Angiotech Announces Preliminary Third Quarter Financial Results and Updates Fiscal 2007 Outlook
- October 11Angiotech Receives CE Mark Approval of Quill™ SRS MONODERM™, a New Rapidly Resorbing Suture Product Line
- October 9Angiotech Announces Intent to File 510(K) for its Innovative 5-FU Central Venous Catheter (CVC) Based on Positive Results from Pivotal Trial
- September 20Angiotech Announces Further European Expansion of the Quill™ SRS PDO Product Line
- September 19Angiotech to Participate in UBS Global Life Sciences Conference
- September 17Angiotech Reaches Agreement with Johnson and Johnson to Settle Outstanding Patent Litigation
- September 13Angiotech Receives Favourable Patent Decision from New Zealand's Intellectual Property Office
- August 29Hemo-Stream™ Chronic Dialysis Catheter Receives FDA Clearance
- August 15Angiotech Announces Additional Diameters of Sutures To Further Expand Its Quill™ SRS PDO Product Line
- August 13Angiotech Announces Expansion of Innovative Quill™ SRS Product Line With New Choice Of Absorbable Sutures
- August 2Angiotech Reports Second Quarter Results
- August 2Angiotech Appoints Laura Brege to its Board of Directors
- July 31Notice of Conference Call and Webcast: Angiotech's Second Quarter 2007 Financial Results
- July 19Angiotech's Corporate Partner, Boston Scientific, Announces First Implant of TAXUS® Element™ Platinum Chromium Stent
- July 18Angiotech's Corporate Partner, Boston Scientific, Announces First Human Use of TAXUS® Petal™ Bifurcation Stent
- July 18Angiotech's Corporate Partner, Cook Medical, Announces Enrollment in Pivotal Study of Paclitaxel-coated Stent for Use Outside the Heart
- July 10Angiotech Completes Enrolment In Its Central Venous Catheter (CVC) Pivotal Study
- June 27Angiotech to Participate in Jefferies Healthcare Conference
- June 12CombinatoRx and Angiotech Extend Research and Development Collaboration to Create Next Generation Drug Device and Local Delivery Medicines
- May 31Angiotech to Hold Annual Analyst Day
- May 29Angiotech Initiates European Trial Examining the Vascular Wrap&trade Paclitaxel-Eluting Mesh for Dialysis Patients with End-Stage Renal Disease
- May 29Angiotech to Participate in Bank of America Conference
- May 17Angiotech Receives European Approval for Quill® SRS Wound Closure Product
- May 10Angiotech to Market Vascular Wrap™ / ePTFE Graft Combination Product Through Its Own European Sales and Distribution Networks
- May 8Angiotech's Corporate Partner, Boston Scientific, Announces Japanese Launch of TAXUS® Express2&trade Coronary Stent System - Reimbursement Granted by National Health Insurance System
- May 2Angiotech Reports First Quarter Results
- April 26Two-year Data for Angiotech's Vascular Wrap™ Paclitaxel-Eluting Mesh to be Presented at European Vascular Symposium
- April 18Notice of Conference Call and Webcast: Angiotech's First Quarter 2007 Financial Results
- April 3Angiotech's Corporate Partner, Boston Scientific, Announces Japanese Approval for the TAXUS® Express2™ Stent System
- April 3Angiotech Appoints Chris Dennis As Senior Vice President, Sales And Marketing
- March 22Angiotech appoints Santi Corsaro Vice President, Sales and Marketing OUS
- March 19Angiotech Initiates U.S. Pivotal Trial for the Vascular Wrap™ Paclitaxel-Eluting Mesh
- March 15Angiotech Receives Favourable Decision From The European Patent Office
- March 7Angiotech Appoints Victor Diaz As Senior Vice President, Global Manufacturing and Supply Chain Management
- February 1Angiotech Reports Fourth Quarter Results and Updates 2007 Financial Outlook
- January 24Angiotech Launches the Quill® Self-Retaining System (SRS) - Establishing a New "Class" of Wound Closure Products
- January 17Angiotech Wins Patent Infringement Case in the Netherlands
- January 16UK Court of Appeal Releases Decision on Angiotech Patent
News
Quick Links
© Copyright 2010 Angiotech. All Rights Reserved.